BioStock: Chosa develops next generation chemotherapy

The chemotherapy cisplatin has been a staple in cancer treatment since the 1980s. However, not all cancer patients respond to the drug, and the side effects are quite severe. Chosa Oncology is looking to tackle both of these drawbacks with its iCIP concept. BioStock has taken a closer look at this revolutionary cancer treatment and how the company is working to take it to the next level.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/06/chosa-develops-next-generation-chemotherapy/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se